8 February 2024
BIOPHARMA
CREDIT PLC
("BIOPHARMA CREDIT" OR THE "COMPANY")
DIVIDEND
DECLARATION
2.96 CENT PER SHARE DISTRIBUTION INCLUDES 1.2
CENT SPECIAL
DECLARATION
BioPharma Credit PLC (LSE: BPCR),
the specialist life sciences debt investor, is pleased to declare
an interim dividend in respect of the financial period ending 31
December 2023 of $0.02957930 per ordinary share, payable on 15
March 2024 to ordinary shareholders on the register as at 16
February 2024. The ex-dividend date will be 15 February 2024. The
Company has chosen to designate the entire amount of this interim
dividend as an interest distribution. Shareholders in receipt of
such a dividend will be treated for UK tax purposes as though they
have received a payment of interest. This will result in a
reduction in the corporation tax payable by the Company.
The $0.02957930 dividend
comprises an ordinary dividend of $0.0175 and a special
dividend of $0.01207930. The Company is currently paying and
continues to target a 7 cent annual dividend per ordinary share.
This will bring total dividends for 2023 to 10.21 cents including
special dividends totalling 3.21 cents.
The default payment for dividends is
in US dollars. However, shareholders can elect to have dividends
paid in sterling (GBP) and the option to elect a sterling dividend
payment for this dividend will be available to shareholders until
16 February 2024 (the "Election Date").
Further details together with a copy
of the Dividend Currency Election Form, which should be sent to
Link Group, 10th Floor, Central Square, 29
Wellington Street, Leeds LS1 4DL when completed, will be
available on the Group's website shortly
at www.bpcruk.com/investor-materials.
CREST shareholders must elect via CREST. Further details together
with a copy of the Dividend Currency Election Form, which should be
sent to Link Group, 10th Floor, Central Square, 29
Wellington Street, Leeds LS1 4DL when completed, will be
available on the Group's website shortly
at www.bpcruk.com/investor-materials.
CREST shareholders must elect via CREST.
Enquiries:
BioPharma Credit plc
via Link Company Matters
Limited
Company Secretary
+44 (0) 333 300 1950
Buchanan
David Rydell / Mark Court
/ Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit
PLC is London's only specialist debt investor to the
life sciences industry and joined the LSE in March
2017. BioPharma Credit PLC seeks to provide long-term
shareholder returns, principally in the form of sustainable income
distributions from exposure to the life sciences
industry. BioPharma Credit PLC seeks to achieve this
objective primarily through investments in debt assets secured by
royalties or other cash flows derived from the sales of approved
life sciences products.
LEI: 213800AV55PYXAS7SY24